However, compounds which improve insulin sensitivity and glucose intolerance are somewhat limited warranting the discovery and characterization of novel molecules targeting various pathways involved in the pathogenesis of type-2 diabetes [28]. Here, INS is linked to type 2 diabetes mellitus.